Developed using novel mini promoters to enhance geneexpression and a PWS-minigene adeno-associated virus (AAV) vector, it may be possible to treat this neurodevelopmental disorder. • Developmental disorders involving multiple genes. Given the large number of genes involved in PWS, traditional gene therapy is not a feasible option due to limits in delivering more than one gene using AAV vectors.